Thyroid storm case study
The case
Patient: A 42‑year‑old woman, previously healthy, presents to the emergency department (ED) with a 12‑hour history of worsening agitation, palpitations, and profuse sweating.
Presenting complaint: “I feel like my heart is racing and I cannot stop shaking.”
History of present illness:
- Onset was sudden early this morning after she missed her scheduled dose of carbimazole (40 mg daily) for the past three days while on a business trip.
- She reports a 3‑month history of weight loss (~5 kg), heat intolerance, and occasional tremor.
- Over the past week she has had intermittent diarrhea and a mild fever (up to 38.2 °C).
- Yesterday she attended a social event where she consumed 3–4 glasses of red wine and a large amount of coffee (≈400 mg caffeine).
- No recent infections, trauma, or surgeries.
Past medical history:
- Diagnosed with Graves’ disease 2 years ago; on carbimazole 40 mg daily and propranolol 40 mg twice daily.
- No known cardiac disease, diabetes, or hypertension.
Medication history:
- Carbimazole 40 mg daily (missed last 3 doses).
- Propranolol 40 mg twice daily (taken as prescribed).
- No over‑the‑counter or herbal supplements.
Family history: Mother with hypothyroidism; father died of myocardial infarction at 58 y.
Social history: Non‑smoker, occasional alcohol, works as a marketing manager, lives with husband.
Examination (ED, within 30 min of arrival):
| Parameter | Value |
|---|---|
| General | Restless, diaphoretic, tremulous |
| Vitals | Temp 38.5 °C, HR 138 bpm (regular), BP 150/90 mm Hg, RR 24 /min, SpO₂ 98 % on room air |
| Neck | Diffusely enlarged, non‑tender thyroid; no bruit |
| Cardiovascular | Tachycardia, regular rhythm, no murmurs, no peripheral edema |
| Respiratory | Clear bilaterally |
| Abdomen | Soft, mild hyperactive bowel sounds |
| Neurologic | Fine tremor of outstretched hands, agitation, no focal deficits |
| Skin | Warm, flushed, moist; no pretibial myxedema |
Initial investigations (STAT):
| Test | Result | Units |
|---|---|---|
| CBC | Hb 13.2, WBC 11.4, Platelets 210 | g/dL, ×10⁹/L |
| Electrolytes | Na 138, K 4.2, Cl 102, HCO₃⁻ 24 | mmol/L |
| Renal | BUN 12, Creatinine 0.9 | mg/dL |
| Liver | AST 32, ALT 28, ALP 78 | U/L |
| Glucose | 112 | mg/dL |
| Thyroid function | FT₄ 4.8 (NR 0.8‑1.8), FT₃ 9.2 (NR 2.3‑4.2) | ng/dL, pg/mL |
| TSH | <0.01 | µIU/mL |
| Serum cortisol (8 am) | 12 | µg/dL |
| ECG | Sinus tachycardia, no ST‑T changes | |
| Chest X‑ray | Normal cardiac silhouette, clear lungs | |
| Blood cultures | Pending | |
| Urine output (first 2 h) | 150 mL | mL |
The clinical picture fulfills the Burch–Wartofsky Point Scale (BWPS) with a score of 70 (≥45 = thyroid storm).
Questions
- What is the most likely diagnosis?
- Which clinical and laboratory findings support this diagnosis, and why are they pathognomonic?
- Outline the immediate investigations required to confirm the diagnosis and to assess for precipitating factors.
- Describe the step‑by‑step management plan, including drug choices, dosages, and supportive measures, according to the latest (2023) American Thyroid Association (ATA) guidelines.
- List the potential complications of thyroid storm and the strategies to monitor and prevent them.
Answers
1. What is the most likely diagnosis?
Thyroid storm (also called thyrotoxic crisis) – an acute, life‑threatening exacerbation of thyrotoxicosis.
- The patient has known Graves’ disease, missed antithyroid medication, and presents with classic storm features (high fever, severe tachycardia, agitation, gastrointestinal upset).
- The BWPS score of 70 (>45) confirms the diagnosis.
2. Which clinical and laboratory findings support this diagnosis, and why are they pathognomonic?
| Finding | Reason it supports thyroid storm |
|---|---|
| Fever ≥38 °C | Hypermetabolism increases heat production; fever >38 °C is a major BWPS criterion. |
| Tachycardia 138 bpm | Direct β‑adrenergic effect of excess thyroid hormone; HR >130 bpm adds 25 points on BWPS. |
| Agitation & tremor | Central nervous system hyperexcitability from increased catecholamine sensitivity. |
| Diarrhea & abdominal discomfort | Hypermotility of the gut due to thyroid hormone excess. |
| Elevated FT₄ (4.8 ng/dL) and FT₃ (9.2 pg/mL) | Markedly supraphysiologic free hormone levels; FT₃ is the most active form and rises early. |
| Suppressed TSH (<0.01 µIU/mL) | Reflects negative feedback; essentially absent in storm. |
| Recent missed carbimazole doses | Loss of inhibition of thyroid hormone synthesis precipitates storm. |
| Precipitating stress (alcohol, caffeine, infection suspicion) | Known triggers that increase catecholamine surge and cytokine release. |
These findings collectively satisfy the BWPS criteria: temperature (20 points), CNS effects (20), GI‑hepatic (10), cardiovascular (25), and precipitating factor (10).
3. Outline the immediate investigations required to confirm the diagnosis and to assess for precipitating factors.
- Thyroid function panel – FT₄, FT₃, TSH (already obtained).
- Complete blood count & differential – to detect infection or leukocytosis.
- Electrolytes, renal & hepatic panel – baseline for drug dosing and to identify organ dysfunction.
- Blood cultures (2 sets) – rule out bacteremia/sepsis, a common precipitant.
- Urinalysis & urine culture – screen for urinary tract infection.
- Chest radiograph – exclude pneumonia or pulmonary edema.
- ECG & cardiac enzymes (troponin I/T) – assess for arrhythmias or myocardial ischemia secondary to tachycardia.
- Serum cortisol – to exclude adrenal insufficiency, which can mimic or worsen storm.
- Thyroid autoantibodies (TSI, TPO‑Ab) – not urgent for acute management but helpful for long‑term planning.
- Pregnancy test (β‑hCG) – if reproductive age and pregnancy status unknown, as management differs.
All tests should be drawn within the first hour of presentation to guide therapy and identify reversible precipitants.
4. Describe the step‑by‑step management plan, including drug choices, dosages, and supportive measures, according to the latest (2023) ATA guidelines.
Management is multimodal: (i) block hormone synthesis, (ii) block hormone release, (iii) block peripheral effects, (iv) inhibit peripheral conversion, and (v) provide supportive care.
| Step | Intervention | Drug & Dose | Rationale |
|---|---|---|---|
| A. Stabilize airway, breathing, circulation | Supplemental O₂ (2–4 L/min) if SpO₂ < 94 % | • | Prevent hypoxia; tachycardia may precipitate heart failure. |
| B. Control heart rate & adrenergic symptoms | Propranolol (IV) | 1 mg IV over 1 min, repeat q5 min up to 3 mg total; then 0.5 mg/kg IV q6 h or PO 40–80 mg q6 h | Non‑selective β‑blocker reduces HR, tremor, and blocks T₄→T₃ conversion. |
| C. Inhibit new hormone synthesis | Propylthiouracil (PTU) – preferred in storm | 500 mg PO loading, then 250 mg PO q4 h (total 1 g/24 h) OR 250 mg IV q6 h if unable to swallow | PTU blocks thyroid peroxidase and 5′‑deiodinase (peripheral conversion). |
| D. Inhibit hormone release | Iodine (Lugol’s solution or saturated solution of potassium iodide – SSKI) | 1 g PO (5 mL of 10 % solution) every 6 h, administer at least 1 h after PTU | High‑dose iodine induces the Wolff‑Chaikoff effect, halting hormone release. |
| E. Block peripheral conversion (if PTU unavailable or contraindicated) | High‑dose glucocorticoid | Hydrocortisone 100 mg IV bolus, then 100 mg IV q8 h (or dexamethasone 2 mg IV q6 h) | Reduces T₄→T₃ conversion and treats possible relative adrenal insufficiency. |
| F. Supportive care | Aggressive cooling (evaporative, antipyretics), fluid resuscitation (30 mL/kg isotonic saline over first 2 h), electrolyte monitoring, treat precipitating infection (empiric broad‑spectrum antibiotics if sepsis suspected). | • | Fever control prevents further metabolic demand; fluids maintain perfusion. |
| G. Monitoring | ICU admission, continuous cardiac telemetry, serial vitals, urine output ≥0.5 mL/kg/h, repeat labs q6–12 h (FT₄, electrolytes, liver enzymes). | • | Early detection of deterioration (arrhythmia, heart failure). |
| H. Transition to definitive therapy | Once storm controlled (HR < 100 bpm, afebrile, stable), switch to methimazole (if PTU not needed) and plan for radioiodine ablation or total thyroidectomy after euthyroid state achieved (usually 4–6 weeks). | Methimazole 20–30 mg PO daily | Methimazole has a better safety profile for long‑term use. |
Special considerations:
- Pregnancy – PTU is preferred over methimazole in the first trimester; if pregnant, avoid high‑dose iodine.
- Liver dysfunction – PTU hepatotoxicity risk; if LFTs rise >3× ULN, consider switching to methimazole after storm control.
- Beta‑blocker contraindication (asthma, severe COPD) – use dinitrophenol (IV) or calcium channel blocker (e.g., verapamil 0.1 mg/kg IV) for rate control.
5. List the potential complications of thyroid storm and the strategies to monitor and prevent them.
| Complication | Pathophysiology | Monitoring | Prevention / Management |
|---|---|---|---|
| Cardiac arrhythmias (AF, VT, SVT) | Excess catecholamines & hyperthyroidism increase automaticity | Continuous ECG telemetry, serial electrolytes | β‑blockade, control electrolytes (K⁺ > 4 mmol/L), avoid QT‑prolonging drugs |
| High‑output cardiac failure | Tachycardia → increased myocardial O₂ demand, decreased SVR | Daily weight, BNP, bedside echo, urine output | Early rate control, diuretics (furosemide 20–40 mg IV), afterload reduction if needed |
| Acute liver injury | Direct toxic effect of thyroid hormone & PTU | LFTs q12 h, bilirubin | Use lowest effective PTU dose, switch to methimazole once storm resolves |
| Septic shock | Infection is a common precipitant; hypermetabolism masks signs | Blood cultures, lactate, WBC, procalcitonin | Empiric antibiotics (e.g., ceftriaxone + metronidazole) after cultures, source control |
| Thromboembolic events (DVT/PE) | Hypercoagulable state (↑ factor VIII, fibrinogen) | D‑dimer, duplex US if leg swelling, CT‑PA if dyspnea | Early mobilization, consider prophylactic LMWH (enoxaparin 40 mg SC daily) if no bleeding risk |
| Acute adrenal insufficiency | Relative cortisol deficiency in severe illness | Serum cortisol, ACTH stimulation if < 10 µg/dL | Stress‑dose steroids (hydrocortisone 100 mg IV q8 h) as part of regimen |
| Neurologic deterioration (seizure, coma) | Severe hyperthermia & metabolic derangement | Neurologic checks q1 h, EEG if altered mental status persists | Aggressive cooling, correct electrolytes, treat underlying storm promptly |
| Pulmonary edema | Cardiac failure + increased capillary permeability | CXR, O₂ saturation, BNP | Diuretics, oxygen, consider non‑invasive ventilation if needed |
Key learning points
- Thyroid storm is a clinical diagnosis; the Burch–Wartofsky Point Scale ≥45 strongly supports it.
- Missed antithyroid medication, infection, surgery, or excess iodine are common precipitants.
- PTU is the drug of choice in storm because it blocks both hormone synthesis and peripheral conversion; give after a loading dose of PTU, then iodine ≥1 h later.
- β‑blockers (preferably propranolol) provide rapid control of tachycardia and reduce T₄→T₃ conversion.
- High‑dose glucocorticoids serve dual purposes: inhibit conversion and treat possible adrenal insufficiency.
- ICU admission, continuous cardiac monitoring, and aggressive supportive care (cooling, fluid resuscitation) are mandatory.
- Early identification and treatment of precipitating factors (e.g., infection) are as crucial as endocrine therapy.
- Once the storm resolves, transition to methimazole and plan definitive therapy (radioiodine or surgery) after achieving a euthyroid state.
Practice MCQs
1. A 38‑year‑old man with known toxic multinodular goitre presents with fever 39 °C, HR 150 bpm, and agitation. His FT₄ is 5.2 ng/dL, FT₃ 10.8 pg/mL, and TSH <0.01 µIU/mL. Which of the following is the most appropriate first‑line drug to control his heart rate and also decrease peripheral conversion of T₄ to T₃?
A. Metoprolol 5 mg IV
B. Propranolol 1 mg IV
C. Diltiazem 0.25 mg IV
D. Atenolol 50 mg PO
Answer: B — Propranolol at 1 mg IV rapidly reduces heart rate and, uniquely among β‑blockers, inhibits 5′‑deiodinase, decreasing T₄→T₃ conversion.
2. In the management of thyroid storm, the timing of iodine administration relative to antithyroid drugs is critical because:
A. Iodine enhances the effect of PTU if given simultaneously.
B. Iodine can increase thyroid hormone synthesis if given before PTU.
C. Iodine has no effect on hormone release when PTU is used.
D. Iodine should be given before PTU to block hormone release first.
Answer: B — If iodine is administered before an antithyroid drug, the thyroid gland may use the iodine substrate to synthesize more hormone (the Jod‑Basedow phenomenon). Therefore, iodine must be given after PTU (or methimazole) to ensure the organification step is blocked.
3. Which of the following laboratory abnormalities, if observed during a thyroid storm, would most strongly
Get a new patient case, answer the examiner's questions by voice or text, and get marked — free.
Try a case on MEDOSTMore in Medicine
The patient is invented for teaching. AI-assisted study material for exam revision. Always confirm with standard textbooks and current guidelines; not medical advice.